The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

Activists have sharply criticised the US government’s move to exclude South Africa from receiving HIV prevention medication ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

"I was scared and terrified because I was still very young when I received the news. What else was going to save me if the medicines that are supposed to treat me are failing?" wonders Brandon Jaka, a ...

MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).

Either we get ahead of this crisis or watch a generation of Americans be swept into the devastating grip of disease.

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...

Nontuthuzelo Ntwana, a lone warrior in the battle against gender-based violence, faces the grim irony of losing her vital ...